Both common and rare genetic variation play a role in the causes for mood disorders. Very large families pose unique opportunities and analytical challenges but may provide a way to identify regions and mutations associated with mood disorders. We identified a family with a high prevalence (~30%) of mood disorders in a rural village in Brazil, featuring decreasing age of onset over generations. The pattern of inheritance was complex with 32 Bipolar type I cases, 11 Bipolar type II and 59 recurrent and/or severe Depression cases in addition to other phenotypes. We enrolled 333 participants with DNA samples from a broader pedigree of 960 subjects for genotyping using the Affymetrix 10K array.
The World Health Organisation reports depression and bipolar disorder as the second and seventh most important causes of years lost due to disability worldwide [1] . The heritability of bipolar disorder is between 60-90% with a lower but still substantial heritability for major depression (40-45%) [2] ; [3] . First-degree relatives of bipolar disorder probands have a 5-10 fold increase in risk of developing the illness compared to relatives of controls but also show a three fold increase in unipolar depression, indicating that bipolar disorder does not "breed true" [4] . Large collaborative genome-wide association studies (GWAS) have uncovered several common genetic variants of small effect [5] . Genomewide estimates of heritability suggest that up to 60% of the genetic risk is contributed by common variants [6] . Overall, the current picture for bipolar disorder (and almost all complex traits) is a genetic architecture formed of both common and rare variants.
Linkage studies have been pursued on the basis that there may be variants of greater effect shared between and within affected families. However these studies have usually focused on collections of comparatively small families or sib pairs and few consistent findings have emerged [7] . Large multigenerational families (e. g. of >30 affected individuals) theoretically offer a powerful means for mapping complex disease loci that are individually rare but common in a single family. These loci may be more highly penetrant and of larger effect than loci found with GWAS [8] . Here we report the results of the Brazilian Bipolar Family (BBF) study on a five-generation family of 639 members of which 333 were enrolled in the current analyses. Our objectives were to perform a linkage analysis with genome coverage and try to identify new genes/mutations related to bipolar and other mood disorders in the family. Here we report our findings and preliminary results of sequencing of linkage regions.
Methods

Family Ascertainment
The Brazilian Bipolar Family (BBF) consists of 960 members. Ascertainment was via a 45-year-old female proband with severe Type-1 BP, who was treated by one of the psychiatrists involved in the study (M.D). She stated that there were dozens of cases of mood disorders in the family, most of whom lived in a small village in a rural area of a state north of São Paulo. Cooperation from the family and a within family published book about the history of the family, self-published within the family, was invaluable for our ascertainment.
The grandparents of the proband were reported to be first cousins and both suffered from BP1 disorder. Of their 13 children, 12 had a confirmed bipolar mood disorder and many of them went on to have affected children. Notably, one of them went on to give birth to 14 affected children. The BBF also exhibits other features, including anticipation; an apparent pattern of earlier age of onset in affected individuals in successive generations.
Family members >16 years of age underwent semi-structured interviews, using the Portuguese version of the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID) [9] . Members aged 6-16 were assessed using the Portuguese version of Kiddie-SADS-Present and Lifetime Version (K-SADS-PL) [10] . In total 308 interviews were completed, and 5 eligible members declined an interview.
Discrepancies in diagnoses were reviewed by two independent psychiatrists and a final consensus diagnosis was assigned. The family had an obvious division, with densely affected large branches from the village and nearby forming a core that we termed "Branch 1" and the rest of the family, which has less densely affect branches, and had migrated to urban areas around south-eastern Brazil.
Phenotype Models
Three phenotypic models were constructed for the analyses: a narrow, broad, and super model, in addition to a depression only model. The narrow affection model included family members that fulfilled DSM-IV criteria for BPI, BPII, or schizoaffective disorder. The broad model included family members in the narrow model in addition to family members who fulfilled DSM-IV criteria for BPNOS and cyclothymia. The super model included cases from the broad model and those with one or more episodes of major depression of moderate to severe MDD or who fulfilled diagnostic criteria for dysthymia as defined by DSM-IV. Finally, family members were included in the depression model if they had a history of dysthymia or experienced one episode of major depression (Table 1) . Non interviewed family members were given the status "unknown". Individuals who were interviewed and did not receive any mood (or other psychiatric) disorder diagnosis were labelled as "unaffected" in the analyses.
Sample Collection and Genotyping
Following diagnostic interview, interviewers obtained 30ml of whole blood in 4 7.5 ml (EDTA containing) monovettes for adults and lesser amounts or saliva for 8 adults and 17 children given personal preference or age (DNA Genotek Inc., Ontario, Canada). Genomic DNA was isolated from whole blood and saliva at the Federal University of São Paulo using standard procedures. In total, 333 DNA samples were extracted, of which 324 were genotyped using the Affymetrix 10K microarray. One sample with discordant sex information was removed from the data set.
We excluded SNPs on genotype missingness (>10%), a minor allele frequency <25% in BBF founders (n=54) and deviation from HWE in founders only (p<10 -4 ).
5315 SNPs remained available for analysis. Pedigree structure, Mendelian and non-Mendelian errors were estimated using PLINK pair-wise IBD estimation, PEDSTATS [11] and MERLIN [12] with MERLIN's "pedwipe" function used to remove them. We also used the McLinkage Check Errors procedure to calculate the posterior probability of genotype mistyping at each marker in the data (given the observed genotypes in relatives), which were incorporated into subsequent 
Structure of Analysis
Following completion of the QC procedures, 301 BBF members and 5315 were available for analysis. Four clean pedigree files were generated for the analyses:
(a) the Branch 1 (village) sub-families, (b) All BBF sub-families, (c) Branch 1 with structure intact and (d) Total BBF with structure intact.
Inheritance Models
Guided by large family studies from similar populations [13] , [14] , we specified dominant and recessive models. We assumed 1% penetrance for zero copies of the disease allele (i.e. phenocopy rate), 81% for one copy, and 90% for two copies, and 1%,1% and 90% for the recessive model. Under the dominant model, disease allele frequencies assumed were 0.003, 0.03, and 0.13 for the narrow, broad, and super phenotype models (reflecting prevalence estimates of 1.5%, 5% and 20%). Under the recessive model, disease allele frequencies assumed were 0.07, 0.03, and 0.46 for each phenotype.
We also performed analyses on a depression only model. Using a population prevalence for recurrent or long (>6 months) single episode severe major depression of 5%, and a penetrance estimate of 50%, we specified disease allele frequency of 0.005 and parameter penetrances of 5%, 50% and 50% for a dominant model and 5%, 5% and 50% for a recessive model with a disease allele frequency of 0.05 (dominant) and 0.33 (recessive) as previously used for the analysis of depression pedigrees by our group [2] . Genotypes of BBF founders allowed estimation of population specific marker allele frequencies [15] .
We use the map provided with the array, with additional checking and mapping of SNPs to the reference genome (data not shown).
Parametric Linkage Analysis using McLinkage
Two-point parametric linkage on the BBF and Branch 1 was conducted using TwoPointLods, part of the McLinkage package. For reasons of computation, regions reaching suggestive or significant thresholds in 2-point linkage were analysed using McLinkage multipoint parametric linkage, which samples from the posterior distribution of inheritance vectors, given the observed genotypes, and calculates multipoint LOD scores (MLOD) and TLOD scores between the specified phenotype and genetic markers in a pedigree [16] .
Merlin Analyses
Linkage analysis programs, such as MERLIN, that use the Lander-Green [17] exact LOD score calculation require large pedigrees to be split. We first split the BBF into 19 (<30 bit) sub-families, preserving family relatedness, such as first cousin marriages and complex marriage loops where possible, prior to breaking these loops. Two-point and multipoint parametric linkage analysis was conducted on 19 subfamilies belonging to all three branches of the family, and 12 subfamilies belonging to Branch 1 of the family using the models described above. Heterogeneity LOD (HLOD) scores were also calculated.
We also employed MERLIN to conduct multipoint NPL methods of linkage analysis, examining both affected relative pairs, NPL pairs , and affected subgroups within the family, NPL all , for allele sharing by descent. We selected the Kong and Cox (1997) exponential model flag in MERLIN (--exp) to convert NPL pairs and NPL all Z-scores to LOD scores and used MERLIN --trim to drop non-informative family members from the analysis.
Whole-genome Linkage Thresholds:
We used a threshold of LOD ≥ 3 and LOD ≥ 2 as indicative of whole-genome significant and suggestive linkage in our analyses [18] . We corrected for multiple testing using the formula of Ott, as used in [2] LOD -log 10 (number of independent tests performed)
We used the Matrix Spectral Decomposition (matSpD) method to estimate the equivalent number of independent tests performed in our analyses 
Sequencing Methods
Paired-end 100bp whole exome sequencing on Illumina HiSeq 2000 for 29 individuals was outsourced to BGI (Beijing Genomics Institute). In brief,
SOAPaligner was used for alignment to hg19 using default settings and allowing a maximum of 3 mismatches and SOAPsnp for assembly of consensus sequence and genotype calls, using default prior probabilities (novel hom 0.0005 and novel het 0.001) and refining SNP calling using known information (-2 option). Upon reception, files were converted to VCF4.0 and additional filters were applied: minimum read depth 30, maximum read depth 300 and quality 30 or higher using VCFtools v0.1.12a [19] . Ts/Tv ratios of remaining variants fell between 2.2 and 2.4. 2 individuals were excluded due to overall poor QC metrics.
SNP and indels within linkage regions were then annotated using ANNOVAR [20] May 2014 version and databases.
Variants were filtered using the following criteria; <1% or <0.1% in any population in the Exome Aggregation Database and functional relevance (non-synonymous exonic SNV, stopgain or stoploss for SNVs). Finally, we required the variant to be present in at least 2 affected individuals for the particular phenotype and in a maximum of 1 unaffected and 1 married-in individual. In addition, we filtered our variants against a Brazilian population dataset, consisting of 604 exomes available from collaborators (see acknowledgments). We also screened the mutations in the EXAC database (http://exac.broadinstitute.org/ 11/08/15, see acknowledgments), which includes a large number of psychiatric exomes.
Results
Socio-demographics and Psychiatry Phenotype description
In total 111 (36%) interviewed family members received a mood disorder diagnosis. Forty (13%) family members fulfilled criteria for BPI, BPII, or SAD, which increased to 52 (16.9%) when BPNOS and cyclothymia were considered.
More women (62.9%) reported mood disorders and BPI and BPII (61.3%).
Unipolar depression was 17.3%; primary anxiety disorder prevalence was 13.2%;
and alcohol abuse was 20.3% but not associated with mood disorders (data not shown).
One family member had schizoaffective disorder, four family members had learning disability, six had adjustment disorder, and five children were diagnosed with Attention Deficient Hyperactivity Disorder. The BBF also had higher than expected rates of autoimmune hypothyroidism (7.8%), type I diabetes (10.1%) and Parkinson's disease (2.6%).
Summary of Whole-Genome Linkage and Sequencing Results
Using the corrected whole-genome significant and suggestive thresholds, four chromosomal regions resulted in whole-genome significant LOD scores: 2p23. The findings from our study on chromosomes 11p15, 12p13.32-p13.31 and OMIM 213300), which is marked by ataxia, hypotonia and other features. Both syndromes were not observed in family members but do point to the neuronal importance of TCTN2. However, this finding is tentative and requires further study within the family and replication.
We found a genome-wide significant linkage on chromosome 2p23.1-p22.3, under the super phenotype model. The region is 7.5 Mb distal to a region of possible linkage reported by [24] in Portuguese Island families with multiple patients suffering from BPD and schizophrenia. We found a convincing mutation in FAM98A that was shared by 7 of 14 cases with high read depth sequencing data and good quality scores. However, the gene encodes a protein of broadly unknown function that is part of family of proteins (including the paralogous expressed across a large of species and tissues called the DUF2465
superfamily.
The region with the most substantial evidence for linkage was chromosome 11p15.4, under the depression phenotype model. Approximately 2.6 Mb telomeric to the BBF linkage peak, Zubenko et al. [25] reported a depression susceptibility locus with significant evidence for linkage (maximum LOD=4.20)
using recurrent MDD families. The findings of Zubenko et al. [25] are difficult to interpret given the thirteen chromosomal regions reaching significant linkage in their analysis. However, this region has also been implicated in bipolar disorder [26] . Our sequencing results yielded a relatively large number of plausible mutations that we were unable to select between using objective criteria. For example, mutations have been reported in the cadherin receptor DCHS1 that lead to a recessive syndrome in humans that includes periventricular neuronal heterotopia [27] .
Chromosome 22q11.21-q12.1 achieved high genome-wide suggestive evidence for linkage in the BBF (LOD=3.76) under a recessive mood of disease transmission for the broad phenotype. Genome-wide significance was also previously obtained for loci on chromosome 22q12 for BPI using NPL methods [13] and parametric methods [28] . Moreover, chromosome 22q11.2 is deleted in velocardio-facial syndrome, as first reported by Driscoll [29] , which is associated with schizophrenic symptoms [30] . This locus shows a substantial decline in LOD scores observed with the inclusion of depression cases in analysis. We did not find mutations in this region that pass our QC filters.
Other regions, where we find no sequencing variants after filtering in the regions, [32] , and multiplex bipolar families [33] [34]. The linkage peak on 12p13.32 had been previously implicated in both BPD and schizophrenia. This region was implicated in general mood disorders in a study of Columbian bipolar families [35] . The second most significant linkage region was found on chromosome 3p25.3-p24.1 identified using the narrow phenotype model and a dominant mode of inheritance. In related phenotypes, a larger region on chromosome 3p26-p21 was implicated in
Indonesian families with schizophrenia [36] and the nearby 3p25-24 in severe recurrent depression [37] .
In conclusion, we have found strong evidence for linkage in regions for bipolar disorder, broad mood disorders and also for depression alone. Some of the regions are underlain by mutations in neuronally expressed genes that are carried by affected family members. The TCTN2 and, in particular, FAM98A
mutations are of interest. However, our mutation findings must be regarded as preliminary and will require replication and follow up of mutation carriers in the family. Nevertheless, this family is an unique resource, our results so far are highly promising and our follow up of these results will including integration of common variation polygenic scores as well as tracking of mutation carriers within the family. 
